Buntin Melinda Beeuwkes, Garber Alan M, McClellan Mark, Newhouse Joseph P
RAND Health, Arlington, VA 22202, USA.
Health Serv Res. 2004 Feb;39(1):111-30. doi: 10.1111/j.1475-6773.2004.00218.x.
To discuss and quantify the incentives that Medicare managed care plans have to avoid (through selective enrollment or disenrollment) people who are at risk for very high costs, focusing on Medicare beneficiaries in the last year of life-a group that accounts for more than one-quarter of Medicare's annual expenditures.
Medicare administrative claims for 1994 and 1995.
We calculated the payment a plan would have received under three risk-adjustment systems for each beneficiary in our 1995 sample based on his or her age, gender, county of residence, original reason for Medicare entitlement, and principal inpatient diagnoses received during any hospital stays in 1994. We compared these amounts to the actual costs incurred by those beneficiaries. We then looked for clinical categories that were predictive of costs, including costs in a beneficiary's last year of life, not accounted for by the risk adjusters.
The analyses were conducted using claims for a 5 percent random sample of Medicare beneficiaries who died in 1995 and a matched group of survivors.
Medicare is currently implementing the Principal Inpatient Diagnostic Cost Groups (PIP-DCG) risk adjustment payment system to address the problem of risk selection in the Medicare+Choice program. We quantify the strong financial disincentives to enroll terminally ill beneficiaries that plans still have under this risk adjustment system. We also show that up to one-third of the selection observed between Medicare HMOs and the traditional fee-for-service system could be due to differential enrollment of decedents. A risk adjustment system that incorporated more of the available diagnostic information would attenuate this disincentive; however, plans could still use clinical information (not included in the risk adjustment scheme) to identify beneficiaries whose expected costs exceed expected payments.
More disaggregated prospective risk adjustment methods and alternative payment systems that compensate plans for delivering care to certain classes of patients should be considered to ensure access to high-quality managed care for all beneficiaries.
探讨并量化医疗保险管理式医疗计划为避免(通过选择性参保或退保)成本极高风险人群而产生的激励措施,重点关注生命最后一年的医疗保险受益人——这一群体占医疗保险年度支出的四分之一以上。
1994年和1995年医疗保险行政索赔数据。
根据1995年样本中每位受益人的年龄、性别、居住县、医疗保险资格的原始原因以及1994年任何住院期间接受的主要住院诊断,我们计算了该计划在三种风险调整系统下本应收到的支付金额。我们将这些金额与这些受益人的实际成本进行了比较。然后,我们寻找能够预测成本的临床类别,包括受益人生命最后一年的成本,而这些成本未被风险调整因素所涵盖。
分析使用了1995年死亡的医疗保险受益人的5%随机样本索赔数据以及一组匹配的幸存者数据。
医疗保险目前正在实施主要住院诊断成本组(PIP-DCG)风险调整支付系统,以解决医疗保险+选择计划中的风险选择问题。我们量化了在这种风险调整系统下,计划在招收绝症受益人方面仍然存在的强烈经济抑制因素。我们还表明,医疗保险健康维护组织(HMO)与传统按服务收费系统之间观察到的高达三分之一的选择差异可能归因于死者的不同参保情况。纳入更多可用诊断信息的风险调整系统将减弱这种抑制因素;然而,计划仍可利用(风险调整方案中未包括的)临床信息来识别预期成本超过预期支付的受益人。
应考虑采用更细化的前瞻性风险调整方法和替代支付系统,对为特定类别的患者提供护理的计划进行补偿,以确保所有受益人都能获得高质量的管理式医疗服务。